Participant no. | Site A: home (11/20 observations) | Site B: clinic (9/20 observations) | ||||
---|---|---|---|---|---|---|
PSA safe start | EPDS | DV | PSA safe start | EPDS | DV | |
1 | ✓ | |||||
2 | ✓ | ✓ | ||||
3 | ✓ | |||||
4 | ✓ | |||||
5 | ✓ | |||||
7 | ✓ | ✓ | ✓ | |||
8 | ✓ | ✓ | ✓ | |||
9 | ✓ | ✓ | ✓ | |||
11 | ✓ | ✓ | ✓ | |||
12 | ✓ | ✓ | ✓ | |||
14 | ✓ | ✓ | ✓ | |||
15 | ✓ | |||||
17 | ✓ | ✓ | ||||
18 | ✓ | ✓ | ||||
21 | ✓ | ✓ | ✓ | |||
24 | ✓ | |||||
25 | ✓ | ✓ | ||||
26 | ✓ | ✓ | ✓ | |||
30 | ✓ | ✓ | ✓ | |||
33 | ✓ | ✓ | ✓ |